Xiaozheng Kang

2.2k total citations
68 papers, 976 citations indexed

About

Xiaozheng Kang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Xiaozheng Kang has authored 68 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 30 papers in Surgery and 17 papers in Oncology. Recurrent topics in Xiaozheng Kang's work include Esophageal Cancer Research and Treatment (22 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Xiaozheng Kang is often cited by papers focused on Esophageal Cancer Research and Treatment (22 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Xiaozheng Kang collaborates with scholars based in China, Ethiopia and United States. Xiaozheng Kang's co-authors include Wanpu Yan, Ke‐Neng Chen, Hongchao Xiong, Ke‐Neng Chen, Liang Dai, Jianhao Lin, Zhen Liang, Yongbo Yang, Yuqing Zhang and Liang Dai and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaozheng Kang

62 papers receiving 966 citations

Peers

Countries citing papers authored by Xiaozheng Kang

Since Specialization

Citations

This map shows the geographic impact of Xiaozheng Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozheng Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozheng Kang more than expected).

Fields of papers citing papers by Xiaozheng Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozheng Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozheng Kang. The network helps show where Xiaozheng Kang may publish in the future.

Co-authorship network of co-authors of Xiaozheng Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozheng Kang. A scholar is included among the top collaborators of Xiaozheng Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozheng Kang. Xiaozheng Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Periarterial divestment following neoadjuvant therapy in patients with locally advanced pancreatic cancer with celiac axis invasion: A safe and effective surgical procedure 2025 ·Surgery ·(unknown), Jianwei Qin, Kailian Zheng, Xinyu Liu, Xiaohan Shi, (unknown), (unknown), Suizhi Gao, Cheng Wu, Xiaoyi Yin, Meilong Shi, Xiaozheng Kang, (unknown), Shiwei Guo, Wei Jing, Gang Jin	1
2	cfDNA hydroxymethylcytosine profiling for detection metastasis and recurrence of Esophageal Squamous Cell Carcinoma 2025 ·World Journal of Surgical Oncology ·(unknown), (unknown), Long Chen, Lei Zhang, Xuehui Li, (unknown), (unknown), Yingzhu Chen, Haitao Zhou, Zhen Liang, Guobing Xu, (unknown), Jian Lin, Xiaozheng Kang	2
3	A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma 2025 ·Translational Oncology ·Bo Li, Meilong Shi, Yang Wang, Penghao Li, (unknown), (unknown), Xiaozheng Kang, Huan Wang, Suizhi Gao, Kailian Zheng, Xiaohan Shi, Xiongfei Xu, Yukun Zhou, Hui Jiang, Jing Wei, Shiwei Guo, (unknown)	0
4	Isoliquiritigenin alleviates neuropathic pain by reducing microglia inflammation through inhibition of the ERK signaling pathway and decreasing CEBPB transcription expression 2024 ·International Immunopharmacology ·Zikun Wang, Shu Jia, Xiaozheng Kang, (unknown), (unknown), (unknown), Xiao Liang, Chunyang Meng	6
5	Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial 2024 ·Clinical Cancer Research ·(unknown), Xiaozheng Kang, (unknown), Liyan Xue, (unknown), Xiaotian Zhao, Qiuxiang Ou, (unknown), (unknown), Jiao Li, (unknown), (unknown), Zhen Wang, Qingfeng Zheng, Yong Li, Jianjun Qin, Nan Bi, (unknown)	4
6	Efficacy and safety of the combination of tisleizumab with chemoradiotherapy in oligorecurrence esophageal squamous cell carcinoma: A prospective phase II study. 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Nuo Yu, Jiao Li, (unknown), Jianjun Qin, Xiaozheng Kang, Yong Li, Zhen Wang, Xiankai Chen, Ruixiang Zhang, Qingfeng Zheng, Nan Bi, (unknown), Xin Wang	1
7	In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors 2024 ·Molecular Therapy ·Xiaozheng Kang, Yifeng Han, (unknown), Yuxin Li, (unknown), (unknown), Zhengyun Zou, Jie Dong, Jiwu Wei	2
8	Comparative genomic analysis of esophageal squamous cell carcinoma among different geographic regions 2023 ·Frontiers in Oncology ·Ruixiang Zhang, Canjun Li, Zhiyi Wan, Jianjun Qin, Yong Li, Zhen Wang, Qingfeng Zheng, Xiaozheng Kang, Xiankai Chen, Yun Li, Jie He, Yin Li	1
9	Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition) 2023 ·SHILAP Revista de lepidopterología ·Ruixiang Zhang, Zhen Wang, Xiaozheng Kang, Xin Wang, Bo Zhang, (unknown), Liyan Xue, Wenjing Yang, (unknown), (unknown), Lvhua Wang, (unknown)	3
10	Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma 2022 ·SHILAP Revista de lepidopterología ·Zhen Wang, Xiankai Chen, Yong Li, Jianjun Qin, Yuan Fang, Zhaoyang Yang, Yan Fang, (unknown), Ruixiang Zhang, Qingfeng Zheng, Xiaozheng Kang, Liyan Xue, Jing Huang, (unknown), (unknown), Jie He	8
11	A randomized controlled trial of oral nutritional supplementation versus standard diet following McKeown minimally invasive esophagectomy in patients with esophageal malignancy: a pilot study 2021 ·Annals of Translational Medicine ·(unknown), Xiankai Chen, (unknown), Ruixiang Zhang, Xiaozheng Kang, (unknown), Yafan Yang, Yin Li	10
12	Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. 2019 ·PubMed Central ·Wensi Zhao, Wanpu Yan, Dongbo Chen, Liang Dai, Yongbo Yang, Xiaozheng Kang, Hao Fu, Pu Chen, (unknown), Xueyan Wang, Xingwang Xie, Hongsong Chen, Ke‐Neng Chen	24
13	Clinical outcomes following an initial experience with a novel powered vascular stapler in video-assisted thoracoscopic lobectomies: results of a Chinese multi-center study 2019 ·Journal of Thoracic Disease ·Bin Qiu, Xiaozheng Kang, Ke‐Neng Chen, Jian Hu, (unknown), Liping Zeng, (unknown), Michael Schwiers, (unknown), Jason R. Waggoner, Ding Ding, (unknown), Shugeng Gao	4
14	Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy 2018 ·Thoracic Cancer ·Qi Shi, Luyan Shen, Bin Dong, Hao Fu, Xiaozheng Kang, Liang Dai, Yongbo Yang, Wanpu Yan, Ke‐Neng Chen	17
15	The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma 2018 ·Cancer Letters ·Qi Shi, Luyan Shen, Bin Dong, Hao Fu, Xiaozheng Kang, Yongbo Yang, Liang Dai, Wanpu Yan, Hongchao Xiong, Zhen Liang, Ke‐Neng Chen	39
16	[Deficiencies in the Diagnosis and Treatment of Pulmonary Metastatic Osteosarcoma: A Chinese Multidisciplinary Survey]. 2016 ·SHILAP Revista de lepidopterología ·Xiaozheng Kang, Zhen Huang, Anhui Shi, Jie Wang, Dongmei Lin, Ying‐Shi Sun, Guangying Zhu, Xiaohui Niu, Ke‐Neng Chen	1
17	Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo 2015 ·PLoS ONE ·Hui Li, Luyan Shen, Wanpu Yan, Bin Dong, Xiaozheng Kang, Liang Dai, Yongbo Yang, Hao Fu, (unknown), Haitao Zhou, Chuan Huang, Zhen Liang, Hongchao Xiong, Ke‐Neng Chen	19
18	The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment 2015 ·Tumor Biology ·(unknown), Mengying Fan, Liang Dai, Xiaozheng Kang, Yiqiang Liu, Yu Sun, Wanpu Yan, Zhen Liang, Hongchao Xiong, Ke‐Neng Chen	17
19	Personalized targeted therapy for esophageal squamous cell carcinoma 2015 ·World Journal of Gastroenterology ·Xiaozheng Kang	41
20	Cooperative Structure-Directing Effects in the Synthesis of a High-Silica Zeolite Mazzite Analogue 2012 ·Materials Sciences and Applications ·Qi Shi, Jinyang Yu, (unknown), Xiaozheng Kang	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact